GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
Log in

NASDAQ:CLRBCellectar Biosciences Earnings Date, Estimates & History

$1.55
+0.02 (+1.31 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.51
Now: $1.55▼
$1.64
50-Day Range
$1.03
MA: $1.31▼
$1.51
52-Week Range
$1.01
Now: $1.55▼
$3.33
Volume57,161 shs
Average Volume802,285 shs
Market Capitalization$14.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.69

Earnings

Cellectar Biosciences (NASDAQ:CLRB) Earnings Information

Cellectar Biosciences last issued its quarterly earnings results on May 7th, 2020. The biopharmaceutical company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.35) by $0.07. Cellectar Biosciences has generated ($1.84) earnings per share over the last year. Cellectar Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 10th, 2020 based off prior year's report dates.

Cellectar Biosciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cellectar Biosciences (NASDAQ:CLRB) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20201($0.27)($0.27)($0.27)
Q3 20201($0.18)($0.18)($0.18)
Q4 20201($0.19)($0.19)($0.19)

Cellectar Biosciences (NASDAQ CLRB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/10/2020
(Estimated)		       
5/7/20203/31/2020($0.35)($0.42)($0.42)N/A
3/9/202012/31/2019($0.37)($0.33)($0.33)N/A
11/12/2019Q3 2019($0.38)($0.42)($0.42)N/A
8/12/2019Q2 2019($0.6950)($0.46)($0.46)N/A
5/6/2019Q1 2019($0.74)($0.76)($0.76)N/A
11/13/2018Q3 2018($0.83)($1.65)($1.65)N/A
8/10/2018Q2 2018($2.10)($1.69)($1.69)N/A
5/11/2018Q1 2018($2.00)($2.10)($0.21)N/A
3/21/2018Q4 2017($2.30)($3.40)($34.00)Transcript
11/9/2017Q3 2017($2.50)($2.60)($0.26)N/A
8/14/2017Q2 2017($2.40)($2.30)($0.23)N/A
5/11/2017Q1 2017($2.30)($2.40)($0.24)N/A
3/15/2017Q4 2016($2.30)($3.50)($0.36)N/A
11/10/2016Q3 2016($2.00)($4.30)($0.43)N/A
8/11/2016Q2 2016($4.00)($4.90)($0.49)N/A
5/12/2016Q1 2016$9.10$0.91N/A
11/12/2015Q315($2.50)($0.25)Listen
8/12/2015Q215($3.00)($0.30)Listen
5/21/2015Q115($3.00)($0.30)Listen
3/24/2015Q4 2014($22.00)($2.20)N/A
11/11/2014Q3 2014($10.00)($1.00)N/A
8/20/2014Q2 2014($66.00)($5.90)N/A
5/14/2014Q1 2014($100.00)($10.00)N/A
3/25/2014Q4 2013($80.00)($100.00)($6.00)N/A
11/6/2013Q3 2013($100.00)($140.00)$2.00$92.67 millionN/A
8/12/2013Q2 2013($100.00)($100.00)($12.00)N/A
5/15/2013Q1 2013($80.00)($120.00)($10.00)N/A
5/4/2012Q1 2012($120.00)($118.00)($11.60)N/A
3/9/2012Q4 2011($120.00)($12.00)N/A
11/7/2011Q3 2011($142.00)($14.20)N/A
8/18/2011Q2 2011($202.00)($20.20)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.